Search details
1.
Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults.
BMC Infect Dis
; 18(1): 186, 2018 04 18.
Article
in English
| MEDLINE | ID: mdl-29669531
2.
Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older.
J Infect Dis
; 216(11): 1352-1361, 2017 12 12.
Article
in English
| MEDLINE | ID: mdl-29029224
3.
Superior antigen-specific CD4+ T-cell response with AS03-adjuvantation of a trivalent influenza vaccine in a randomised trial of adults aged 65 and older.
BMC Infect Dis
; 14: 425, 2014 Jul 30.
Article
in English
| MEDLINE | ID: mdl-25078387
4.
A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 years.
J Infect Dis
; 207(12): 1878-87, 2013 Jun 15.
Article
in English
| MEDLINE | ID: mdl-23470848
5.
Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years.
BMC Infect Dis
; 13: 343, 2013 Jul 24.
Article
in English
| MEDLINE | ID: mdl-23883186
6.
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial.
Nat Med
; 27(1): 106-114, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33288923
7.
Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial.
Lancet Infect Dis
; 20(1): 80-91, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31630990
8.
Quadrivalent Influenza Vaccine Prevents Illness and Reduces Healthcare Utilization Across Diverse Geographic Regions During Five Influenza Seasons: A Randomized Clinical Trial.
Pediatr Infect Dis J
; 39(1): e1-e10, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31725115
9.
Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts.
NPJ Vaccines
; 4: 51, 2019.
Article
in English
| MEDLINE | ID: mdl-31839997
10.
Anamnestic Immune Response and Safety of an Inactivated Quadrivalent Influenza Vaccine in Primed Versus Vaccine-Naïve Children.
Pediatr Infect Dis J
; 38(2): 203-210, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30325891
11.
Clinical Presentation of Influenza in Children 6 to 35 Months of Age: Findings From a Randomized Clinical Trial of Inactivated Quadrivalent Influenza Vaccine.
Pediatr Infect Dis J
; 38(8): 866-872, 2019 08.
Article
in English
| MEDLINE | ID: mdl-31306399
12.
Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons.
Lancet Child Adolesc Health
; 2(5): 338-349, 2018 05.
Article
in English
| MEDLINE | ID: mdl-30169267
13.
A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control.
Hum Vaccin Immunother
; 13(7): 1640-1652, 2017 07 03.
Article
in English
| MEDLINE | ID: mdl-28532276
14.
Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis.
Hum Vaccin Immunother
; 12(12): 3043-3055, 2016 12.
Article
in English
| MEDLINE | ID: mdl-27690762
15.
Immunogenicity and safety of inactivated quadrivalent and trivalent influenza vaccines in children 18-47 months of age.
Pediatr Infect Dis J
; 33(12): 1262-9, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25386965
16.
AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial.
Lancet Infect Dis
; 13(6): 485-96, 2013 Jun.
Article
in English
| MEDLINE | ID: mdl-23518156
Results
1 -
16
de 16
1
Next >
>>